Zero Candida Technologies (TSXV:ZCT) Change In Receivables: C$0.08 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSXV:ZCT Zero Candida Technologies Inc TSXV:ZCT
14 GF Score
Price C$0.15
! 1 Warning Sign
View Full Analysis

What is Zero Candida Technologies Change In Receivables?

Zero Candida Technologies TSXV:ZCT 14 Change In Receivables is C$0.08 Mil as of Dec. 2025. GuruFocus rates TSXV:ZCT with a GF Score™ of 14/100. The stock has 1 warning sign investors should review.

Zero Candida Technologies's change in receivables for the quarter that ended in Dec. 2025 was C$0.00 Mil. It means Zero Candida Technologies's Accounts Receivable stayed the same from Sep. 2025 to Dec. 2025 .

Zero Candida Technologies's change in receivables for the fiscal year that ended in Dec. 2025 was C$0.00 Mil. It means Zero Candida Technologies's Accounts Receivable stayed the same from Jul. 2024 to Dec. 2025 .

Zero Candida Technologies's Accounts Receivable for the quarter that ended in Dec. 2025 was C$0.00 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Zero Candida Technologies's liquidation value for the three months ended in Dec. 2025 was C$1.18 Mil.

Zero Candida Technologies  (TSXV:ZCT) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Zero Candida Technologies's Days Sales Outstanding for the quarter that ended in Dec. 2025 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=0/0*91
=

2. In Ben Graham's calculation of liquidation value, Zero Candida Technologies's accounts receivable are only considered to be worth 75% of book value:

Zero Candida Technologies's liquidation value for the quarter that ended in Dec. 2025 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=2.241-1.057+0.75 * 0+0.5 * 0
=1.18

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zero Candida Technologies Change In Receivables Related Terms

Zero Candida Technologies Change In Receivables Historical Data

* Premium members only.

The historical data trend for Zero Candida Technologies's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zero Candida Technologies Change In Receivables Chart

Zero Candida Technologies Annual Data
Trend Jul23 Jul24 Dec25
Change In Receivables
0.00 0.00 0.00

Zero Candida Technologies Quarterly Data
Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Mar25 Jun25 Sep25 Dec25
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.05 0.02 0.00 0.00
TSXV:ZCT
14GF Score
Zero Candida Technologies Inc TSXV:ZCT
Change In Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zero Candida Technologies Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.08 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Receivables →
What does a Change In Receivables of C$0.08 Mil mean?
Zero Candida Technologies (TSXV:ZCT) has a Change In Receivables of C$0.08 Mil as of Dec. 2025. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for Zero Candida Technologies and its competitors.
Is Zero Candida Technologies' Change In Receivables too high?
Zero Candida Technologies' current Change In Receivables is C$0.08 Mil. Overall, Zero Candida Technologies has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Zero Candida Technologies' Change In Receivables compare to ABT and SYK?
Zero Candida Technologies' Change In Receivables of C$0.08 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Receivables for a Medical Devices & Instruments company?
A good Change In Receivables depends on the Medical Devices & Instruments industry context. However, Change In Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Receivables mean?
A high Change In Receivables can signal that a stock is expensive relative to its fundamentals. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for Zero Candida Technologies and its competitors. Zero Candida Technologies's current Change In Receivables is C$0.08 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zero Candida Technologies stock overvalued right now?
Zero Candida Technologies (TSXV:ZCT) has a current Change In Receivables of C$0.08 Mil. The current Change In Receivables is C$0.08 Mil. Zero Candida Technologies' overall GF Score™ is 14/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Receivables calculated?
Change In Receivables is calculated from a company's financial statements. For Zero Candida Technologies (TSXV:ZCT), the current Change In Receivables is C$0.08 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Zero Candida Technologies Business Description

Address 666 Burrard Street, Suite 500, Vancouver, BC, CAN, V6C 3P6
Zero Candida Technologies Inc is engaged in providing female healthcare solutions. The company technology uses a controlled Blue Light to destroy the fungus at record speed and without side effects. It focused on developing and commercializing several patents and patent applications concerning an AI smart tampon-like device, designed to treat Candidiasis and transfer medical information via Wi-Fi to the doctor.
14GF Score

Get the complete analysis for TSXV:ZCT

Change In Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

C$0.15
Price